Home › Neoplasms by Histologic Type › Illinois › Chicago
Neoplasms by Histologic Type clinical trials in Chicago, IL
4 studies for Neoplasms by Histologic Type are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RecruitingObservational study
- Northwestern University, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecruitingPhase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPhase 1/2
- University of Chicago Medical Center, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- University of Chicago, Chicago
Neoplasms by Histologic Type trials in other cities
- Atlanta, GA5 studies
- Boston, MA5 studies
- Los Angeles, CA4 studies
- Houston, TX4 studies
- Baldwin Park, CA3 studies
- San Francisco, CA3 studies
- New York City, NY3 studies
- Dallas, TX3 studies
- Nashville, TN3 studies
- St. Louis, MO3 studies
- Clifton, NJ3 studies
- Tampa, FL3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer62 studies
- Breast Cancer58 studies
- Cancer (all types)53 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity42 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke35 studies
- Heart Failure32 studies
- Colorectal Cancer32 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.